(October 13, 2017, 2:12 PM EDT) -- WASHINGTON, D.C. — Review of an Eighth Circuit U.S. Court of Appeals panel ruling in a shareholder derivative lawsuit brought on behalf of a medical device maker over the company’s alleged involvement in an illegal off-market labeling scheme for one of its devices is necessary to cure a split among the circuit courts as to the proper standard of review for a shareholder derivative action based on a federal district court’s dismissal of the action after the issuance of a special litigation committee’s (SLC) report, an investor argues in a Sept. 8 petition for writ of certiorari filed in the U.S. Supreme Court (Charlotte Kokocinski, derivatively on behalf of Medtronic Inc., v. Arthur Collins Jr., et al., No. 17-375, U.S. Sup., 2017 U.S. S. Ct. Briefs 3478)....